The event provided a unique opportunity for attendees to learn the latest commercial developments, strategies and deal forecasts from noted experts.
Freerks was a speaker on the panel, “Fundamentals: Avoiding Transaction Pitfalls-Licensing and Regulatory Compliance.” The panel covered the following topics:
- Structuring the transaction- asset vs. stock deals
- Importance of due diligence review
- Licenses to be aware of
- Change of Ownership (CHOW)/Change of Information (CHOI)
- Tips to regulatory success during a transaction
For more information visit the AHLA website.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.